{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:39:47Z","timestamp":1787002787851,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41433-019-0664-z","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T04:22:43Z","timestamp":1576210963000},"page":"1662-1671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom"],"prefix":"10.1038","volume":"34","author":[{"name":"on behalf of the British Oculoplastic Surgery Society (BOPSS) and TEAMeD","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9047-3589","authenticated-orcid":false,"given":"Parizad","family":"Avari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Perros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"key":"664_CR1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1530\/EJE-11-0548","volume":"165","author":"M Abraham-Nordling","year":"2011","unstructured":"Abraham-Nordling M, Bystr\u00f6m K, T\u00f6rring O, Lantz M, Berg G, Calissendorff J, et al. Incidence of hyperthyroidism in Sweden. Eur J Endocrinol. 2011;165:899\u2013905.","journal-title":"Eur J Endocrinol"},{"key":"664_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0625-1","volume":"12","author":"P Perros","year":"2017","unstructured":"Perros P, Hegedus L, Bartalena L, Marcocci C, Kahaly GJ, Baldeschi L, et al. Graves\u2019 orbitopathy as a rare disease in Europe: a European Group on Graves\u2019 Orbitopathy (EUGOGO) position statement. Orphanet J Rare Dis. 2017;12:72.","journal-title":"Orphanet J Rare Dis"},{"key":"664_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1210\/jc.2012-3119","volume":"98","author":"KA Ponto","year":"2013","unstructured":"Ponto KA, Merkesdal S, Hommel G, Pitz S, Pfeiffer N, Kahaly GJ. Public health relevance of Graves\u2019 orbitopathy. J Clin Endocrinol Metab. 2013;98:145\u201352.","journal-title":"J Clin Endocrinol Metab"},{"key":"664_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/bjo.88.1.75","volume":"88","author":"JJ Park","year":"2004","unstructured":"Park JJ, Sullivan TJ, Mortimer RH, Wagenaar M, Perry-Keene DA. Assessing quality of life in Australian patients with Graves\u2019 ophthalmopathy. Br J Ophthalmol. 2004;88:75\u20138. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14693779.","journal-title":"Br J Ophthalmol"},{"key":"664_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1517\/14656566.2012.668529","volume":"13","author":"C Marcocci","year":"2012","unstructured":"Marcocci C, Altea MA, Leo M. Treatment options for Graves\u2019 orbitopathy. Expert Opin Pharmacother. 2012;13:795\u2013806.","journal-title":"Expert Opin Pharmacother"},{"key":"664_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1089\/thy.2010.1618","volume":"20","author":"P Perros","year":"2010","unstructured":"Perros P, Wiersinga WM. The Amsterdam Declaration on Graves\u2019 orbitopathy. Thyroid. 2010;20:245\u20136.","journal-title":"Thyroid."},{"key":"664_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.7861\/clinmedicine.15-2-173","volume":"15","author":"P Perros","year":"2015","unstructured":"Perros P, Dayan CM, Dickinson AJ, Ezra D, Estcourt S, Foley P, et al. Management of patients with Graves\u2019 orbitopathy: initial assessment, management outside specialised centres and referral pathways. Clin Med. 2015;15:173\u20138.","journal-title":"Clin Med"},{"key":"664_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"L Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, et al. Consensus statement of the European Group on Graves\u2019 orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158:273\u201385.","journal-title":"Eur J Endocrinol"},{"key":"664_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, et al. The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves\u2019 Orbitopathy. Eur Thyroid J. 2016;5:9\u201326.","journal-title":"Eur Thyroid J"},{"key":"664_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1530\/EJE-09-0383","volume":"161","author":"S Estcourt","year":"2009","unstructured":"Estcourt S, Hickey J, Perros P, Dayan C, Vaidya B. The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey. Eur J Endocrinol. 2009;161:483\u20137.","journal-title":"Eur J Endocrinol"},{"key":"664_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/01676830.2017.1280057","volume":"36","author":"FE Mellington","year":"2017","unstructured":"Mellington FE, Dayan CM, Dickinson AJ, Hickey JL, MacEwen CJ, McLaren J, et al. Management of thyroid eye disease in the United Kingdom: a multi-centre thyroid eye disease audit. Orbit. 2017;36:159\u201369.","journal-title":"Orbit."},{"key":"664_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1530\/eje.1.02201","volume":"155","author":"P Perros","year":"2006","unstructured":"Perros P, Baldeschi L, Boboridis K, Dickinson AJ, Hullo A, Kahaly GJ, et al. A questionnaire survey on the management of Graves\u2019 orbitopathy in Europe. Eur J Endocrinol. 2006;155:207\u201311.","journal-title":"Eur J Endocrinol"},{"key":"664_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/eje.0.1480491","volume":"148","author":"MF Prummel","year":"2003","unstructured":"Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourits MP, Kendall-Taylor P, et al. Multi-center study on the characteristics and treatment strategies of patients with Graves\u2019 orbitopathy: the first European Group on Graves\u2019 Orbitopathy experience. Eur J Endocrinol. 2003;148:491\u20135.","journal-title":"Eur J Endocrinol"},{"key":"664_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/eye.2011.323","volume":"26","author":"P Perros","year":"2012","unstructured":"Perros P, Chandler T, Dayan CM, Dickinson AJ, Foley P, Hickey J, et al. Orbital decompression for Graves\u2019 orbitopathy in England. Eye. 2012;26:434\u20137.","journal-title":"Eye."},{"key":"664_CR15","unstructured":"Draman MS, Mitchell A, Dayan C. TEAMeD-5: improving outcomes in thyoid eye disease | Society for Endocrinology. Endocrinologist. 2017;(125). https:\/\/www.endocrinology.org\/endocrinologist\/125-autumn17\/features\/teamed-5-improving-outcomes-in-thyoid-eye-disease\/."},{"key":"664_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10792-013-9768-9","volume":"34","author":"JD Benzimra","year":"2014","unstructured":"Benzimra JD, Quinn AG, Kersey T, McGrane D, Goss L, Vaidya B. Management of patients in a combined thyroid eye clinic in secondary care. Int Ophthalmol. 2014;34:1\u20136.","journal-title":"Int Ophthalmol"},{"key":"664_CR17","unstructured":"Avari C, Bravis V, Robinson S, Meeran K, Lee V. Sharing and caring? Perspectives of multidisciplinary working between endocrinologists and ophthalmologists in thyroid eye disease | Society for Endocrinology. Endocrinologist. 2018;(129). https:\/\/www.endocrinology.org\/endocrinologist\/129-autumn18\/general-news\/sharing-and-caring-perspectives-of-multidisciplinary-working-between-endocrinologists-and-ophthalmologists-in-thyroid-eye-disease\/."},{"key":"664_CR18","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1136\/bjo.2004.046193","volume":"88","author":"R Ebner","year":"2004","unstructured":"Ebner R, Devoto MH, Weil D, Bordaberry M, Mir C, Martinez H, et al. Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol. 2004;88:1380\u20136.","journal-title":"Br J Ophthalmol"},{"key":"664_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/IOP.0000000000001120","volume":"34","author":"SM Young","year":"2018","unstructured":"Young SM, Kim YD, Lang SS, Woo KI. Transconjunctival triamcinolone injection for upper lid retraction in thyroid eye disease-a new injection method. Ophthal Plast Reconstr Surg. 2018;34:587\u201393.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"664_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S2213-8587(18)30021-4","volume":"6","author":"R Rajendram","year":"2018","unstructured":"Rajendram R, Taylor PN, Wilson VJ, Harris N, Morris OC, Tomlinson M, et al. Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2\u2009\u00d7\u20092 factorial, double-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2018;6:299\u2013309.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"664_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S2213-8587(18)30020-2","volume":"6","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly GJ, Riedl M, Konig J, Pitz S, Ponto K, Diana T, et al. Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves\u2019 orbitopathy (MINGO): a randomised, observer-masked, multicentre trial. Lancet Diabetes Endocrinol. 2018;6:287\u201398.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"664_CR22","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.ophtha.2005.10.060","volume":"113","author":"L Baldeschi","year":"2006","unstructured":"Baldeschi L, Wakelkamp IM, Lindeboom R, Prummel MF, Wiersinga WM. Early versus late orbital decompression in Graves\u2019 orbitopathy: a retrospective study in 125 patients. Ophthalmology. 2006;113:874\u20138.","journal-title":"Ophthalmology."},{"key":"664_CR23","doi-asserted-by":"publisher","first-page":"E458","DOI":"10.1210\/jc.2014-3146","volume":"100","author":"AL Mitchell","year":"2015","unstructured":"Mitchell AL, Goss L, Mathiopoulou L, Morris M, Vaidya B, Dickinson AJ, et al. Diagnosis of Graves\u2019 orbitopathy (DiaGO): results of a pilot study to assess the utility of an office tool for practicing endocrinologists. J Clin Endocrinol Metab. 2015;100:E458\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"664_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.beem.2011.11.007","volume":"26","author":"PJ Dolman","year":"2012","unstructured":"Dolman PJ. Evaluating Graves\u2019 orbitopathy. Best Pr Res Clin Endocrinol Metab. 2012;26:229\u201348.","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"664_CR25","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1210\/jc.2009-0506","volume":"94","author":"G Vannucchi","year":"2009","unstructured":"Vannucchi G, Campi I, Covelli D, Dazzi D, Curro N, Simonetta S, et al. Graves\u2019 orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis. J Clin Endocrinol Metab. 2009;94:3381\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"664_CR26","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1089\/thy.2014.0037","volume":"24","author":"S Wickwar","year":"2014","unstructured":"Wickwar S, McBain HB, Ezra DG, Hirani SP, Rose GE, Newman SP. What are the psychosocial outcomes of treatment for thyroid eye disease? A systematic review. Thyroid. 2014;24:1407\u201318.","journal-title":"Thyroid."},{"key":"664_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1530\/EJE-11-0055","volume":"164","author":"S Estcourt","year":"2011","unstructured":"Estcourt S, Quinn AG, Vaidya B. Quality of life in thyroid eye disease: impact of quality of care. Eur J Endocrinol. 2011;164:649\u201355.","journal-title":"Eur J Endocrinol"},{"key":"664_CR28","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1016\/j.ophtha.2015.08.030","volume":"122","author":"S Wickwar","year":"2015","unstructured":"Wickwar S, McBain H, Ezra DG, Hirani SP, Rose GE, Newman SP. The psychosocial and clinical outcomes of orbital decompression surgery for thyroid eye disease and predictors of change in quality of life. Ophthalmology. 2015;122:2568\u201376.e1","journal-title":"Ophthalmology."},{"key":"664_CR29","unstructured":"The Royal College of Ophthalmologists. New Guidelines for Thyroid Eye Disease. 2015. https:\/\/www.rcophth.ac.uk\/2015\/07\/new-guidelines-for-thyroid-eye-disease\/."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0664-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0664-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0664-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:08:59Z","timestamp":1684602539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-019-0664-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1038\/s41433-019-0664-z","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,13]]},"assertion":[{"value":"26 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ben Williams is the Webmaster for BOPSS and is renumerated for providing IT support. None of the other authors or contributors have any conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}